blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4048236

EP4048236 - METHODS OF TREATING PROSTATE CANCER [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  29.07.2022
Database last updated on 26.06.2024
FormerThe international publication has been made
Status updated on  01.05.2021
Formerunknown
Status updated on  24.11.2020
Most recent event   Tooltip15.09.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Arvinas Operations, Inc.
5 Science Park
395 Winchester Avenue
New Haven, CT 06511 / US
[2022/35]
Inventor(s)01 / CREW, Andrew P.
2 Winterberry Road
Guilford, Connecticut 06437 / US
02 / HASKELL, III, Royal J.
71R Banta Lane
Durham, Connecticut 06422 / US
03 / MOORE, Marcia Dougan
283
Prospect Street Suffield, Connecticut 06078 / US
04 / SNYDER, Lawrence B.
85 Laurel Ridge Trail
Killingworth, Connecticut 06419 / US
05 / WANG, Jing
25 Elm Street
Milford, Connecticut 06460 / US
 [2022/35]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[2022/35]
Application number, filing date20807571.321.10.2020
[2022/35]
WO2020US56684
Priority number, dateUS201962924655P22.10.2019         Original published format: US 201962924655 P
US201962945418P09.12.2019         Original published format: US 201962945418 P
US202063028843P22.05.2020         Original published format: US 202063028843 P
US202063032453P29.05.2020         Original published format: US 202063032453 P
[2022/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021081108
Date:29.04.2021
Language:EN
[2021/17]
Type: A1 Application with search report 
No.:EP4048236
Date:31.08.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 29.04.2021 takes the place of the publication of the European patent application.
[2022/35]
Search report(s)International search report - published on:EP29.04.2021
ClassificationIPC:A61K31/02, A61K31/166, A61K31/277, A61K31/497, A61K45/06, A61P35/00
[2022/35]
CPC:
A61K45/06 (EP,IL); C07D401/14 (KR); A61K31/501 (IL,US);
A61K31/02 (EP,IL); A61K31/166 (EP,IL); A61K31/277 (EP,IL);
A61K31/497 (EP,IL); A61K31/506 (KR); A61K9/0053 (IL,US);
A61P35/00 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/35]
Extension statesBA12.05.2022
ME12.05.2022
Validation statesMA12.05.2022
MD12.05.2022
TN12.05.2022
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON PROSTATAKREBS[2022/35]
English:METHODS OF TREATING PROSTATE CANCER[2022/35]
French:MÉTHODES DE TRAITEMENT DU CANCER DE LA PROSTATE[2022/35]
Entry into regional phase12.05.2022National basic fee paid 
12.05.2022Designation fee(s) paid 
12.05.2022Examination fee paid 
Examination procedure12.05.2022Examination requested  [2022/35]
12.05.2022Date on which the examining division has become responsible
07.12.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
15.09.2022Renewal fee patent year 03
14.09.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2018071606  (ARVINAS INC [US]) [X] 1-30* table 8; compounds 399-408,414,421,549 *
by applicantUS4522811
 US2018099940
 US10584101
    - Pharmacol. Rev., (20060000), vol. 58, no. 4, pages 782 - 97
    - Vitam. Horn., (19990000), vol. 55, pages 309 - 52
    - Endocr. Rev., (19870000), vol. 8, no. 1, pages 1 - 28
    - Mol. Endocrinol., (20020000), vol. 16, no. 10, pages 2181 - 7
    - Endocr. Rev., (20040000), vol. 25, no. 2, pages 276 - 308
    - Nat. Rev. Drug Discovery, (20130000), vol. 12, pages 823 - 824
    - BUNDGAARD, Methods in Enzymology, Academic Press, (19850000), vol. 4
    - Design and Application of Prodrugs, Textbook of Drug Design and Development, (19910000), vol. 5, pages 13 - 191
    - BUNDGAARD et al., Journal of Drug Deliver Reviews, (19920000), vol. 8, pages 1 - 38
    - BUNDGAARD, J. of Pharmaceutical Sciences, vol. 77, page 285
    - Advanced Drug Delivery Reviews, (19960000), vol. 19, page 115
    - European Urology, (20180400), vol. 73, no. 4, pages 572 - 582
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.